Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

DBD vs FISV

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
DBD
Diebold Nixdorf, Incorporated

Software - Application

TechnologyNYSE • US
Market Cap$2.75B
5Y Perf.+342.8%
FISV
Fiserv, Inc.

Information Technology Services

TechnologyNASDAQ • US
Market Cap$30.38B
5Y Perf.-53.2%

DBD vs FISV — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
DBD logoDBD
FISV logoFISV
IndustrySoftware - ApplicationInformation Technology Services
Market Cap$2.75B$30.38B
Revenue (TTM)$3.86B$21.09B
Net Income (TTM)$110M$3.20B
Gross Margin26.0%60.8%
Operating Margin8.0%24.4%
Forward P/E14.4x7.0x
Total Debt$1.17B$29.12B
Cash & Equiv.$387M$798M

DBD vs FISVLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

DBD
FISV
StockAug 23May 26Return
Diebold Nixdorf, In… (DBD)100442.8+342.8%
Fiserv, Inc. (FISV)10046.8-53.2%

Price return only. Dividends and distributions are not included.

Quick Verdict: DBD vs FISV

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: FISV leads in 5 of 7 categories, making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. Diebold Nixdorf, Incorporated is the stronger pick specifically for recent price momentum and sentiment. As sector peers, any of these can serve as alternatives in the same allocation.
DBD
Diebold Nixdorf, Incorporated
The Long-Run Compounder

DBD is the clearest fit if your priority is long-term compounding and sleep-well-at-night.

  • 289.1% 10Y total return vs FISV's 9.7%
  • Lower volatility, beta 1.21, current ratio 1.30x
  • +79.3% vs FISV's -68.8%
Best for: long-term compounding and sleep-well-at-night
FISV
Fiserv, Inc.
The Income Pick

FISV carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • beta 0.94
  • Rev growth 3.6%, EPS growth 17.8%, 3Y rev CAGR 6.1%
  • Beta 0.94, current ratio 1.03x
Best for: income & stability and growth exposure
See the full category breakdown
CategoryWinnerWhy
GrowthFISV logoFISV3.6% revenue growth vs DBD's 1.5%
ValueFISV logoFISVLower P/E (7.0x vs 14.4x)
Quality / MarginsFISV logoFISV15.2% margin vs DBD's 2.8%
Stability / SafetyFISV logoFISVBeta 0.94 vs DBD's 1.21
DividendsTieNeither stock pays a meaningful dividend
Momentum (1Y)DBD logoDBD+79.3% vs FISV's -68.8%
Efficiency (ROA)FISV logoFISV4.0% ROA vs DBD's 2.9%, ROIC 8.1% vs 14.0%

DBD vs FISV — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

DBDDiebold Nixdorf, Incorporated
FY 2025
Service
57.0%$2.2B
Product
43.0%$1.6B
FISVFiserv, Inc.
FY 2024
Processing And Services
81.3%$16.6B
Product
18.7%$3.8B

DBD vs FISV — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLDBDLAGGINGFISV

Income & Cash Flow (Last 12 Months)

FISV leads this category, winning 4 of 6 comparable metrics.

FISV is the larger business by revenue, generating $21.1B annually — 5.5x DBD's $3.9B. FISV is the more profitable business, keeping 15.2% of every revenue dollar as net income compared to DBD's 2.8%. On growth, DBD holds the edge at +6.0% YoY revenue growth, suggesting stronger near-term business momentum.

MetricDBD logoDBDDiebold Nixdorf, …FISV logoFISVFiserv, Inc.
RevenueTrailing 12 months$3.9B$21.1B
EBITDAEarnings before interest/tax$400M$7.5B
Net IncomeAfter-tax profit$110M$3.2B
Free Cash FlowCash after capex$266M$4.0B
Gross MarginGross profit ÷ Revenue+26.0%+60.8%
Operating MarginEBIT ÷ Revenue+8.0%+24.4%
Net MarginNet income ÷ Revenue+2.8%+15.2%
FCF MarginFCF ÷ Revenue+6.9%+19.0%
Rev. Growth (YoY)Latest quarter vs prior year+6.0%-2.0%
EPS Growth (YoY)Latest quarter vs prior year+163.6%-29.1%
FISV leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

FISV leads this category, winning 5 of 6 comparable metrics.

At 9.0x trailing earnings, FISV trades at a 71% valuation discount to DBD's 31.1x P/E. On an enterprise value basis, FISV's 6.6x EV/EBITDA is more attractive than DBD's 7.6x.

MetricDBD logoDBDDiebold Nixdorf, …FISV logoFISVFiserv, Inc.
Market CapShares × price$2.7B$30.4B
Enterprise ValueMkt cap + debt − cash$3.5B$58.7B
Trailing P/EPrice ÷ TTM EPS31.05x8.96x
Forward P/EPrice ÷ next-FY EPS est.14.37x7.01x
PEG RatioP/E ÷ EPS growth rate0.25x
EV / EBITDAEnterprise value multiple7.64x6.63x
Price / SalesMarket cap ÷ Revenue0.72x1.43x
Price / BookPrice ÷ Book value/share2.66x1.21x
Price / FCFMarket cap ÷ FCF10.43x7.00x
FISV leads this category, winning 5 of 6 comparable metrics.

Profitability & Efficiency

DBD leads this category, winning 7 of 9 comparable metrics.

FISV delivers a 12.4% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $10 for DBD. DBD carries lower financial leverage with a 1.06x debt-to-equity ratio, signaling a more conservative balance sheet compared to FISV's 1.13x. On the Piotroski fundamental quality scale (0–9), DBD scores 6/9 vs FISV's 5/9, reflecting solid financial health.

MetricDBD logoDBDDiebold Nixdorf, …FISV logoFISVFiserv, Inc.
ROE (TTM)Return on equity+10.1%+12.4%
ROA (TTM)Return on assets+2.9%+4.0%
ROICReturn on invested capital+14.0%+8.1%
ROCEReturn on capital employed+14.1%+10.2%
Piotroski ScoreFundamental quality 0–965
Debt / EquityFinancial leverage1.06x1.13x
Net DebtTotal debt minus cash$787M$28.3B
Cash & Equiv.Liquid assets$387M$798M
Total DebtShort + long-term debt$1.2B$29.1B
Interest CoverageEBIT ÷ Interest expense6.68x6.39x
DBD leads this category, winning 7 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

DBD leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in DBD five years ago would be worth $38,342 today (with dividends reinvested), compared to $4,829 for FISV. Over the past 12 months, DBD leads with a +79.3% total return vs FISV's -68.8%. The 3-year compound annual growth rate (CAGR) favors DBD at 56.5% vs FISV's -22.0% — a key indicator of consistent wealth creation.

MetricDBD logoDBDDiebold Nixdorf, …FISV logoFISVFiserv, Inc.
YTD ReturnYear-to-date+23.3%-13.4%
1-Year ReturnPast 12 months+79.3%-68.8%
3-Year ReturnCumulative with dividends+283.4%-52.5%
5-Year ReturnCumulative with dividends+283.4%-51.7%
10-Year ReturnCumulative with dividends+289.1%+9.7%
CAGR (3Y)Annualised 3-year return+56.5%-22.0%
DBD leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

Evenly matched — DBD and FISV each lead in 1 of 2 comparable metrics.

FISV is the less volatile stock with a 0.94 beta — it tends to amplify market swings less than DBD's 1.21 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. DBD currently trades 88.6% from its 52-week high vs FISV's 29.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricDBD logoDBDDiebold Nixdorf, …FISV logoFISVFiserv, Inc.
Beta (5Y)Sensitivity to S&P 5001.21x0.94x
52-Week HighHighest price in past year$89.05$191.91
52-Week LowLowest price in past year$43.61$52.91
% of 52W HighCurrent price vs 52-week peak+88.6%+29.6%
RSI (14)Momentum oscillator 0–10047.436.5
Avg Volume (50D)Average daily shares traded460K5.3M
Evenly matched — DBD and FISV each lead in 1 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Wall Street rates DBD as "Buy" and FISV as "Buy". Consensus price targets imply 31.4% upside for FISV (target: $75) vs 26.8% for DBD (target: $100).

MetricDBD logoDBDDiebold Nixdorf, …FISV logoFISVFiserv, Inc.
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$100.00$74.64
# AnalystsCovering analysts1360
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises0
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap+4.8%+19.4%
Insufficient data to determine a leader in this category.
Key Takeaway

FISV leads in 2 of 6 categories (Income & Cash Flow, Valuation Metrics). DBD leads in 2 (Profitability & Efficiency, Total Returns). 1 tied.

Best OverallDiebold Nixdorf, Incorporat… (DBD)Leads 2 of 6 categories
Loading custom metrics...

DBD vs FISV: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is DBD or FISV a better buy right now?

For growth investors, Fiserv, Inc.

(FISV) is the stronger pick with 3. 6% revenue growth year-over-year, versus 1. 5% for Diebold Nixdorf, Incorporated (DBD). Fiserv, Inc. (FISV) offers the better valuation at 9. 0x trailing P/E (7. 0x forward), making it the more compelling value choice. Analysts rate Diebold Nixdorf, Incorporated (DBD) a "Buy" — based on 13 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — DBD or FISV?

On trailing P/E, Fiserv, Inc.

(FISV) is the cheapest at 9. 0x versus Diebold Nixdorf, Incorporated at 31. 1x. On forward P/E, Fiserv, Inc. is actually cheaper at 7. 0x.

03

Which is the better long-term investment — DBD or FISV?

Over the past 5 years, Diebold Nixdorf, Incorporated (DBD) delivered a total return of +283.

4%, compared to -51. 7% for Fiserv, Inc. (FISV). Over 10 years, the gap is even starker: DBD returned +289. 1% versus FISV's +9. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — DBD or FISV?

By beta (market sensitivity over 5 years), Fiserv, Inc.

(FISV) is the lower-risk stock at 0. 94β versus Diebold Nixdorf, Incorporated's 1. 21β — meaning DBD is approximately 29% more volatile than FISV relative to the S&P 500. On balance sheet safety, Diebold Nixdorf, Incorporated (DBD) carries a lower debt/equity ratio of 106% versus 113% for Fiserv, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — DBD or FISV?

By revenue growth (latest reported year), Fiserv, Inc.

(FISV) is pulling ahead at 3. 6% versus 1. 5% for Diebold Nixdorf, Incorporated (DBD). On earnings-per-share growth, the picture is similar: Diebold Nixdorf, Incorporated grew EPS 677. 3% year-over-year, compared to 17. 8% for Fiserv, Inc.. Over a 3-year CAGR, FISV leads at 6. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — DBD or FISV?

Fiserv, Inc.

(FISV) is the more profitable company, earning 16. 4% net margin versus 2. 5% for Diebold Nixdorf, Incorporated — meaning it keeps 16. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: FISV leads at 26. 9% versus 8. 8% for DBD. At the gross margin level — before operating expenses — FISV leads at 59. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is DBD or FISV more undervalued right now?

On forward earnings alone, Fiserv, Inc.

(FISV) trades at 7. 0x forward P/E versus 14. 4x for Diebold Nixdorf, Incorporated — 7. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for FISV: 31. 4% to $74. 64.

08

Which pays a better dividend — DBD or FISV?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

09

Is DBD or FISV better for a retirement portfolio?

For long-horizon retirement investors, Fiserv, Inc.

(FISV) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 94)). Both have compounded well over 10 years (FISV: +9. 7%, DBD: +289. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between DBD and FISV?

Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: DBD is a small-cap quality compounder stock; FISV is a mid-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

DBD

Quality Business

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Gross Margin > 15%
Run This Screen
Stocks Like

FISV

Quality Business

  • Sector: Technology
  • Market Cap > $100B
  • Net Margin > 9%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform DBD and FISV on the metrics below

Revenue Growth>
%
(DBD: 6.0% · FISV: -2.0%)
Net Margin>
%
(DBD: 2.8% · FISV: 15.2%)
P/E Ratio<
x
(DBD: 31.1x · FISV: 9.0x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.